R B Wetzels1, S U Zuidema, J F M de Jonghe, F R J Verhey, R T C M Koopmans. 1. Department of Primary and Community Care, Center for Family Medicine, Geriatric Care and Public Health, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands. r.wetzels@elg.umcn.nl
Abstract
BACKGROUND: The goal of this study is to determine patterns of psychotropic drug use (PDU), the association with neuropsychiatric symptoms (NPS), and the variability across dementia types in nursing home residents with dementia. In addition, PDU was analyzed across multiple indications. METHODS: This was a prospective cohort study over a two-year period from 2006 to 2008, which involved 14 dementia special care units in nine nursing homes. A total of 117 residents with dementia participated in the study, of whom 35% had Alzheimer's dementia (AD) and 11% vascular dementia (VaD). PDU was classified according to anatomical therapeutic chemical-classification as either "present" or "absent". RESULTS: The majority of residents had moderately severe to severe dementia. At all successive assessments, almost two-thirds of residents received any psychotropic drug (PD) and almost one-third continued to receive any PD. Of all PDs, antipsychotics (APs) were prescribed most frequently. Fewer residents started with antidepressants, but continued to receive antidepressants at higher percentages. Anxiolytics showed an intermittent course, but a subgroup of 9% showed two-year continuation. Once started on PDs at baseline, residents continued to use PDs at high percentages: three-quarters continued to receive APs for at least six months. Half of residents received at least one PD; one-fifth received at least two PDs simultaneously. Residents with AD received more hypnotics and antidementia drugs; residents with VaD received more antipsychotics, antidepressants, anxiolytics and anticonvulsants. CONCLUSIONS: PDs have different utilization patterns, but overall, consistently high continuation rates were found. These results warrant scrutiny of continuous PDU.
BACKGROUND: The goal of this study is to determine patterns of psychotropic drug use (PDU), the association with neuropsychiatric symptoms (NPS), and the variability across dementia types in nursing home residents with dementia. In addition, PDU was analyzed across multiple indications. METHODS: This was a prospective cohort study over a two-year period from 2006 to 2008, which involved 14 dementia special care units in nine nursing homes. A total of 117 residents with dementia participated in the study, of whom 35% had Alzheimer's dementia (AD) and 11% vascular dementia (VaD). PDU was classified according to anatomical therapeutic chemical-classification as either "present" or "absent". RESULTS: The majority of residents had moderately severe to severe dementia. At all successive assessments, almost two-thirds of residents received any psychotropic drug (PD) and almost one-third continued to receive any PD. Of all PDs, antipsychotics (APs) were prescribed most frequently. Fewer residents started with antidepressants, but continued to receive antidepressants at higher percentages. Anxiolytics showed an intermittent course, but a subgroup of 9% showed two-year continuation. Once started on PDs at baseline, residents continued to use PDs at high percentages: three-quarters continued to receive APs for at least six months. Half of residents received at least one PD; one-fifth received at least two PDs simultaneously. Residents with AD received more hypnotics and antidementia drugs; residents with VaD received more antipsychotics, antidepressants, anxiolytics and anticonvulsants. CONCLUSIONS:PDs have different utilization patterns, but overall, consistently high continuation rates were found. These results warrant scrutiny of continuous PDU.
Authors: Sytse U Zuidema; Alice Johansson; Geir Selbaek; Matt Murray; Alistair Burns; Clive Ballard; Raymond T C M Koopmans Journal: Int Psychogeriatr Date: 2015-06-10 Impact factor: 3.878
Authors: Michaela Defrancesco; Josef Marksteiner; W Wolfgang Fleischhacker; Imrich Blasko Journal: Int J Neuropsychopharmacol Date: 2015-05-19 Impact factor: 5.176
Authors: Ki Jung Chang; Chang Hyung Hong; Yunhwan Lee; Kang Soo Lee; Hyun Woong Roh; Joung Hwan Back; Young Ki Jung; Ki Young Lim; Jai Sung Noh; Hyun Chung Kim; Seong Hye Choi; Seong Yoon Kim; Duk L Na; Sang Won Seo; Soojin Lee; Sang Joon Son Journal: Medicine (Baltimore) Date: 2015-06 Impact factor: 1.889
Authors: Geertje van de Ven; Irena Draskovic; Elke van Herpen; Raymond T C M Koopmans; Rogier Donders; Sytse U Zuidema; Eddy M M Adang; Myrra J F J Vernooij-Dassen Journal: PLoS One Date: 2014-01-28 Impact factor: 3.240
Authors: Claudia M Groot Kormelinck; Charlotte F van Teunenbroek; Sytse U Zuidema; Martin Smalbrugge; Debby L Gerritsen Journal: BMC Geriatr Date: 2021-07-03 Impact factor: 3.921
Authors: Claudia H W Smeets; Martin Smalbrugge; Debby L Gerritsen; Marjorie H J M G Nelissen-Vrancken; Roland B Wetzels; Klaas van der Spek; Sytse U Zuidema; Raymond T C M Koopmans Journal: BMC Psychiatry Date: 2013-11-01 Impact factor: 3.630
Authors: Klaas van der Spek; Debby L Gerritsen; Martin Smalbrugge; Marjorie H J M G Nelissen-Vrancken; Roland B Wetzels; Claudia H W Smeets; Sytse U Zuidema; Raymond T C M Koopmans Journal: BMC Psychiatry Date: 2013-11-15 Impact factor: 3.630